No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Omarigliptin is a drug used to treat type 2 diabetes, a condition in which the body does not produce enough insulin or does not use insulin properly. It belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors, which work by increasing the amount of insulin released by the pancreas. Omarigliptin is used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes. It is also used to reduce the risk of cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.
Omarigliptin is part of the larger Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat a variety of conditions, such as diabetes, obesity, and thyroid disorders. These drugs are used to regulate hormones and metabolism, and can help to improve overall health and quality of life.
Some companies in the Omarigliptin market include AstraZeneca, Merck, and Takeda Pharmaceuticals. Show Less Read more
